Pēdējā atjaunošana :
29/10/2024
Infostab
Saraksti
Kopsavilkums
Meklēt saderības
Y-savienojuma saderības tabula
Literatūras saraksts
pētniecības grupas
valistab
plakāts
Savienojumi
sponsori
Autori
Lietošanas instrukcija
Newsletter
Epirubicin hydrochloride
Ķīmiskā uzbūve
Oriģinālais nosaukums
Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām
Anthracine
Malaizija
Axirubicine
Vācija
Bendaepi
Vācija
Binarin
Meksika
Bioepycina
Polija
Crisabon
Argentīna
Cuatroepi
Argentīna
Ecclepia
Rumānija
Elebicin
Meksika
Ellence
Amerikas Savienotās Valstis
Epi Cell
Vācija
Epidoxo
Argentīna, Čīle, Venecuēla
Epifil
Ekvadora
Epilem
Kolumbija, Meksika
Epimedac
Vācija
Epirubicin
Austrālija, Austrija, Beļģija, Dānija, Islande, Jaunzēlande, Lielbritānija, Saūda Arābija, Šveice, Turcija, Ungārija, Zviedrija
Epirubicina
Argentīna, Ekvadora, Kolumbija, Meksika, Rumānija, Spānija
Epirubicine
Beļģija, Francija, Šveice
Farmarubicin
Turcija
Farmorubicin
Austrija, Brazīlija, Dānija, Grieķija, Norvēģija, Saūda Arābija, Somija, Šveice, Zviedrija
Farmorubicin CSV
Dienvidāfrikas Republika
Farmorubicin PFS
Horvātija, Polija, Slovēnija
Farmorubicin RD
Brazīlija, krievu, Polija, Šveice
Farmorubicin RTU
Holande
Farmorubicina
Brazīlija, Itālija, Portugāle, Spānija
Farmorubicine
Beļģija, Francija
Pharmorubicin
Lielbritānija
Literatūras saraksts : Epirubicin hydrochloride
tips
publicēšana
148
Žurnāls
Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I.
Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525
Žurnāls
De Vroe C, De Muynck C, Remon JP, Samsom M.
A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters.
Int J Pharm 1990 ; 65: 49-56.
683
Žurnāls
Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C.
Epirubicin stability in syringes and glass vials and evaluation of chemical contamination.
Can J Hosp Pharm 1990 ; 43: 265-272.
686
Žurnāls
Wood MJ, Irwin WJ, Scott DK.
Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags.
J Clin Pharm Ther 1990 ; 15: 279-289.
887
Žurnāls
Pujol M, Munoz M, Prat J, Giona V, De Bolos J.
Stability study of epirubicin in NaCl 0.9% injection.
Ann Pharmacotherapy 1997 ; 31: 992-995.
1237
Žurnāls
Keusters L, Stolk LML, Umans R, Van Asten P.
Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation.
Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265
Žurnāls
Wood MJ, Irwin WJ, Scott DK.
Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography.
J Clin Pharm Ther 1990 ; 15: 291-300.
1317
Žurnāls
Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG.
Pharmaceutical aspects of home infusion therapy for cancer patients.
Pharm J 1987 ; 238: 476-478.
1662
Žurnāls
Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1823
Žurnāls
Sewell GJ, Rigby-Jones AE, Priston MJ.
Stability of intravesical epirubicin infusion: a sequential temperature study.
J Clin Pharm Ther 2003 ; 28: 349-353.
1897
Žurnāls
Sautou-Miranda V, Brigas F, Thibault M, Chopineau J.
Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage.
EJHP 2001 ; 7, 3: 108-115.
1955
Žurnāls
Trissel LA, Zhang Y.
Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
Ann Pharmacotherapy 2005 ; 39: 280-283.
2168
Žurnāls
Ozdemir FA, Anilanmert B, Pekin M.
Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution.
Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257
Laboratorija
Stability of epirubicin "Ebewe" infusion solutions.
Ebewe Pharma 2007
3473
Žurnāls
Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B.
Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization.
Int J Pharm 2015 ; 495, 2: 956-962.
3474
Laboratorija
Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3632
Laboratorija
Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics
Hospira 2017
3670
Žurnāls
Sewell G, Massimini M.
Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system.
EJOP 2014 ; 8, 3: 26-30.
3708
plakāts
Sarakbi I, Thiesen J, Krämer I.
Compatibility of epirubicin-loaded DC Beads with different contrast media.
ECOP 2 Krakow 2014
3918
Žurnāls
Sarakbi I, Krämer I.
Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
J Oncol Pharm Practice 2016 ; 22: 749-756.
4352
Žurnāls
Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y.
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
J Clin Pharm Ther 2019 ; 44: 875-882.
Mentions Légales